GM2gangliosidoses
GM2 gangliosidoses are a group of autosomal recessive lysosomal storage disorders caused by deficient activity of beta-hexosaminidase A (Hex A) or by defects in the GM2 activator protein, leading to accumulation of GM2 ganglioside in neurons. In some cases, deficiency of both Hex A and Hex B underlies disease (Sandhoff). The condition encompasses Tay–Sachs disease (Hex A deficiency), Sandhoff disease (Hex A and Hex B deficiency), and GM2 activator protein deficiency (AB variant).
Clinical features vary by onset. Infantile forms present in early infancy with hypotonia, feeding difficulties, rapid
Diagnosis relies on biochemical and genetic testing. Hex A activity is markedly reduced or absent in Tay-Sachs,
Management is supportive, focusing on symptom control, seizures, nutrition, and respiratory care; multidisciplinary teams provide care.
Epidemiology: carrier frequencies are higher for HEXA mutations in Ashkenazi Jews, contributing to disease prevalence in